REFERENCES
1. Melén, E., et al., Allergies
to food and airborne allergens in children and adolescents: role of
epigenetics in a changing environment. Lancet Child Adolesc Health,
2022. 6 (11): p. 810-819.
2. Wong, K.L., et al., Gene
expression profiling reveals the defining features of the classical,
intermediate, and nonclassical human monocyte subsets. Blood, 2011.118 (5): p. e16-e31.
3. Hirai, H., et al.,Prostaglandin D2 Selectively Induces Chemotaxis in T Helper Type 2
Cells, Eosinophils, and Basophils via Seven-Transmembrane Receptor
Crth2. Journal of Experimental Medicine, 2001. 193 (2): p.
255-262.
4. Pérez-Novo, C.A., et al.,CRTH2 mediates the activation of human Th2 cells in response to
PGD2 released from IgE/anti-IgE treated nasal polyp tissue. Allergy,
2010. 65 (3): p. 304-310.
5. Pettipher, R. and T.T. Hansel,Antagonists of the prostaglandin D2 receptor CRTH2. Drug News
Perspect, 2008. 21 (6): p. 317-22.
6. Schuligoi, R., et al., CRTH2
and D-type prostanoid receptor antagonists as novel therapeutic agents
for inflammatory diseases. Pharmacology, 2010. 85 (6): p.
372-82.
7. Cosmi, L., et al., CRTH2 is
the most reliable marker for the detection of circulating human type 2
Th and type 2 T cytotoxic cells in health and disease. European journal
of immunology, 2000. 30 (10): p. 2972-2979.
8. Nagata, K., et al., CRTH2, an
orphan receptor of T-helper-2-cells, is expressed on basophils and
eosinophils and responds to mast cell-derived factor(s). FEBS Letters,
1999. 459 (2): p. 195-199.
9. Tait Wojno, E.D., et al., The
prostaglandin D2 receptor CRTH2 regulates accumulation of group 2 innate
lymphoid cells in the inflamed lung. Mucosal Immunology, 2015.8 (6): p. 1313-1323.
10. Andiappan, A.K., et al.,Allergic airway diseases in a tropical urban environment are
driven by dominant mono-specific sensitization against house dust
mites. Allergy, 2014. 69 (4): p. 501-9.
11. Puan, K.J., et al.,Systematic characterization of basophil anergy. Allergy, 2017.72 (3): p. 373-384.
12. Mitson-Salazar, A., et al.,Hematopoietic prostaglandin D synthase defines a proeosinophilic
pathogenic effector human T(H)2 cell subpopulation with enhanced
function. J Allergy Clin Immunol, 2016. 137 (3): p. 907-18 e9.
13. Wambre, E., et al., A
phenotypically and functionally distinct human T(H)2 cell subpopulation
is associated with allergic disorders. Sci Transl Med, 2017.9 (401).
14. Brozek, J.L., et al.,Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010
revision. J Allergy Clin Immunol, 2010. 126 (3): p. 466-76.
15. Bousquet, J., et al.,Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in
collaboration with the World Health Organization, GA(2)LEN and
AllerGen). Allergy, 2008. 63 Suppl 86 : p. 8-160.
16. Asher, M.I. and S.K. Weiland,The International Study of Asthma and Allergies in Childhood
(ISAAC). ISAAC Steering Committee. Clin Exp Allergy, 1998. 28
Suppl 5 : p. 52-66; discussion 90-1.
17. Lemonnier, N., et al., A
novel whole blood gene expression signature for asthma, dermatitis, and
rhinitis multimorbidity in children and adolescents. Allergy, 2020.75 (12): p. 3248-3260.
18. Chen, H., et al., Cytofkit:
A Bioconductor Package for an Integrated Mass Cytometry Data Analysis
Pipeline. PLOS Computational Biology, 2016. 12 (9): p.
e1005112.
19. Hirahara, K., et al.,Memory-type pathogenic TH2 cells and ILC2s in type 2 allergic
inflammation. J Allergy Clin Immunol, 2021. 147 (6): p.
2063-2066.
20. Simon, D., L.R. Braathen, and
H.U. Simon, Anti-Interleukin-5 Antibody Therapy in Eosinophilic
Diseases. Pathobiology, 2005. 72 (6): p. 287-292.
21. Mishra, A., et al., IL-5
Promotes Eosinophil Trafficking to the Esophagus. The Journal of
Immunology, 2002. 168 (5): p. 2464-2469.
22. Büttner, C., et al.,Monoclonal anti-interleukin‐5 treatment suppresses eosinophil but
not T‐cell functions. European Respiratory Journal, 2003.21 (5): p. 799-803.
23. Varricchi, G., et al.,Interleukin-5 pathway inhibition in the treatment of eosinophilic
respiratory disorders: evidence and unmet needs. Current Opinion in
Allergy and Clinical Immunology, 2016. 16 (2).
24. Mitson-Salazar, A. and C.
Prussin, Pathogenic Effector Th2 Cells in Allergic Eosinophilic
Inflammatory Disease. Front Med (Lausanne), 2017. 4 : p. 165.
25. Upadhyaya, B., et al.,Hierarchical IL-5 expression defines a subpopulation of highly
differentiated human Th2 cells. J Immunol, 2011. 187 (6): p.
3111-20.
26. Endo, Y., et al.,Pathogenic memory type Th2 cells in allergic inflammation. Trends
Immunol, 2014. 35 (2): p. 69-78.
27. Islam, S.A., et al., Mouse
CCL8, a CCR8 agonist, promotes atopic dermatitis by recruiting IL-5+
T(H)2 cells. Nat Immunol, 2011. 12 (2): p. 167-77.